Annual report
7733.TEDINET S100YDN3
Period2025-04-01 → 2026-03-31
Filed2026-06-18
StandardIFRS
ConsolidatedYes
Data checks19 of 19 passed
Key figures · 157
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.01T | 2025-04-01 → 2026-03-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥997.3bn | 2024-04-01 → 2025-03-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥925.8bn | 2023-04-01 → 2024-03-31v | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥881.9bn | 2022-04-01 → 2023-03-31v | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥750.1bn | 2021-04-01 → 2022-03-31v | Cons. | Revenue IFRS (5-year summary) |
| Operating income | ¥97.1bn | 2025-04-01 → 2026-03-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥162.5bn | 2024-04-01 → 2025-03-31 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥94.0bn | 2025-04-01 → 2026-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥159.1bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥43.6bn | 2023-04-01 → 2024-03-31v | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥182.3bn | 2022-04-01 → 2023-03-31v | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥141.7bn | 2021-04-01 → 2022-03-31v | Cons. | Profit loss before tax IFRS (5-year summary) |
| Net income (owners) | ¥68.2bn | 2025-04-01 → 2026-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥117.9bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥242.6bn | 2023-04-01 → 2024-03-31v | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥143.4bn | 2022-04-01 → 2023-03-31v | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥115.7bn | 2021-04-01 → 2022-03-31v | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income | ¥68.2bn | 2025-04-01 → 2026-03-31 | Cons. | Profit loss IFRS |
| Net income | ¥117.9bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss IFRS |
| Total assets | ¥1.54T | at 2026-03-31 | Cons. | Assets IFRS |
| Total assets | ¥1.43T | at 2025-03-31 | Cons. | Assets IFRS |
| Total assets | ¥1.53T | at 2024-03-31v | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥1.51T | at 2023-03-31v | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥1.36T | at 2022-03-31v | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥725.1bn | at 2026-03-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥681.5bn | at 2025-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥812.0bn | at 2026-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥751.7bn | at 2025-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥757.2bn | at 2024-03-31v | Cons. | Equity IFRS |
| Equity (owners) | ¥812.0bn | at 2026-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥751.7bn | at 2025-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥757.2bn | at 2024-03-31v | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥640.1bn | at 2023-03-31v | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥510.2bn | at 2022-03-31v | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥188.0bn | at 2026-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥252.5bn | at 2025-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥340.9bn | at 2024-03-31v | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥205.5bn | at 2023-03-31v | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Cash & equivalents | ¥302.6bn | at 2022-03-31v | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Operating cash flow | ¥100.6bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥190.5bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥42.4bn | 2023-04-01 → 2024-03-31v | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥98.5bn | 2022-04-01 → 2023-03-31v | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥169.7bn | 2021-04-01 → 2022-03-31v | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Investing cash flow | −¥87.4bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥65.5bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | ¥360.0bn | 2023-04-01 → 2024-03-31v | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥58.4bn | 2022-04-01 → 2023-03-31v | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥71.0bn | 2021-04-01 → 2022-03-31v | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Financing cash flow | −¥87.6bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥211.5bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥276.0bn | 2023-04-01 → 2024-03-31v | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥143.2bn | 2022-04-01 → 2023-03-31v | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥40.7bn | 2021-04-01 → 2022-03-31v | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| EPS (basic) | ¥61.32 | 2025-04-01 → 2026-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥102.99 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥199.91 | 2023-04-01 → 2024-03-31v | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥113.22 | 2022-04-01 → 2023-03-31v | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥90.22 | 2021-04-01 → 2022-03-31v | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥61.2 | 2025-04-01 → 2026-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥102.8 | 2024-04-01 → 2025-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥199.44 | 2023-04-01 → 2024-03-31v | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥113.08 | 2022-04-01 → 2023-03-31v | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥90.17 | 2021-04-01 → 2022-03-31v | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| Net assets per share | ¥737.48 | at 2026-03-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥666.54 | at 2025-03-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥649.59 | at 2024-03-31v | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥510.62 | at 2023-03-31v | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥400.75 | at 2022-03-31v | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Equity ratio | 52.8% | at 2026-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 52.4% | at 2025-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 49.4% | at 2024-03-31v | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 42.4% | at 2023-03-31v | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 37.6% | at 2022-03-31v | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| ROE | 8.7% | 2025-04-01 → 2026-03-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 15.6% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 34.7% | 2023-04-01 → 2024-03-31v | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 24.9% | 2022-04-01 → 2023-03-31v | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 25.6% | 2021-04-01 → 2022-03-31v | Cons. | Rate of return on equity IFRS (5-year summary) |
| Employees | 28,138 | at 2026-03-31 | Cons. | Number of employees |
| Employees | 29,297 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 28,838 | at 2024-03-31v | Cons. | Number of employees |
| Employees | 32,805 | at 2023-03-31v | Cons. | Number of employees |
| Employees | 31,557 | at 2022-03-31v | Cons. | Number of employees |
| Revenue | ¥407.0bn | 2025-04-01 → 2026-03-31 | Standalone | Net sales |
| Revenue | ¥389.8bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥379.4bn | 2023-04-01 → 2024-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥380.0bn | 2022-04-01 → 2023-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥378.6bn | 2021-04-01 → 2022-03-31v | Standalone | Net sales (5-year summary) |
| Operating income | ¥30.2bn | 2025-04-01 → 2026-03-31 | Standalone | Operating income |
| Operating income | ¥12.5bn | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Ordinary income | ¥77.2bn | 2025-04-01 → 2026-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥69.5bn | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥135.1bn | 2023-04-01 → 2024-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥152.3bn | 2022-04-01 → 2023-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥57.2bn | 2021-04-01 → 2022-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥100.7bn | 2025-04-01 → 2026-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥70.4bn | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Net income | ¥86.1bn | 2025-04-01 → 2026-03-31 | Standalone | Profit loss |
| Net income | ¥61.7bn | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥293.6bn | 2023-04-01 → 2024-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥130.3bn | 2022-04-01 → 2023-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥84.8bn | 2021-04-01 → 2022-03-31v | Standalone | Net income loss (5-year summary) |
| Total assets | ¥890.6bn | at 2026-03-31 | Standalone | Assets |
| Total assets | ¥913.0bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥954.9bn | at 2024-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥973.6bn | at 2023-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥900.9bn | at 2022-03-31v | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥417.6bn | at 2026-03-31 | Standalone | Liabilities |
| Total liabilities | ¥455.8bn | at 2025-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥473.0bn | at 2026-03-31 | Standalone | Net assets |
| Net assets / equity | ¥457.2bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥512.9bn | at 2024-03-31v | Standalone | Net assets |
| Net assets / equity | ¥418.3bn | at 2023-03-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥357.2bn | at 2022-03-31v | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥41.1bn | at 2026-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥112.1bn | at 2025-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥77.45 | 2025-04-01 → 2026-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥53.89 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥241.97 | 2023-04-01 → 2024-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥102.88 | 2022-04-01 → 2023-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥66.13 | 2021-04-01 → 2022-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥77.3 | 2025-04-01 → 2026-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥53.79 | 2024-04-01 → 2025-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥241.41 | 2023-04-01 → 2024-03-31v | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥102.76 | 2022-04-01 → 2023-03-31v | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥66.1 | 2021-04-01 → 2022-03-31v | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥30 | 2025-04-01 → 2026-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥20 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥18 | 2023-04-01 → 2024-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥16 | 2022-04-01 → 2023-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥14 | 2021-04-01 → 2022-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥429.41 | at 2026-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥405.22 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥439.81 | at 2024-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥333.48 | at 2023-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥280.3 | at 2022-03-31v | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 53.1% | at 2026-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 50.1% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 53.7% | at 2024-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.9% | at 2023-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 39.6% | at 2022-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 18.5% | 2025-04-01 → 2026-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 12.7% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 63.1% | 2023-04-01 → 2024-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 33.6% | 2022-04-01 → 2023-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 24.0% | 2021-04-01 → 2022-03-31v | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 1,114,486,000 | at 2026-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,139,116,000 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,215,147,000 | at 2024-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,266,179,000 | at 2023-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,299,294,000 | at 2022-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Employees | 2,469 | at 2026-03-31 | Standalone | Number of employees |
| Employees | 2,494 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 2,834 | at 2024-03-31v | Standalone | Number of employees |
| Employees | 2,727 | at 2023-03-31v | Standalone | Number of employees |
| Employees | 3,478 | at 2022-03-31v | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 35
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2026-03-31 | 0 pure |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2026-03-31 | ¥1.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2025-04-01 → 2026-03-31 | −¥499m |
| Reconciling Itemsreconciling | capex | 2025-04-01 → 2026-03-31 | ¥895m |
| Reconciling Itemsreconciling | segment assets | at 2026-03-31 | ¥245.4bn |
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2026-03-31 | −¥23.8bn |
| Endoscopicreportable segment | employees | at 2026-03-31 | 17938 pure |
| Gastrointestinal Solutionsreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥61.9bn |
| Gastrointestinal Solutionsreportable segment | segment assets | at 2026-03-31 | ¥735.1bn |
| Gastrointestinal Solutionsreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥136.4bn |
| Surgical And Interventional Solutionsreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥29.5bn |
| Surgical And Interventional Solutionsreportable segment | segment assets | at 2026-03-31 | ¥555.2bn |
| Surgical And Interventional Solutionsreportable segment | segment profit | 2025-04-01 → 2026-03-31 | −¥15.0bn |
| Surgical Interventionreportable segment | employees | at 2026-03-31 | 6856 pure |
| —segment total | capex | 2025-04-01 → 2026-03-31 | ¥91.3bn |
| —segment total | segment assets | at 2026-03-31 | ¥1.29T |
| —segment total | segment profit | 2025-04-01 → 2026-03-31 | ¥121.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2024-04-01 → 2025-03-31 | ¥5m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2025-03-31 | ¥4.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-04-01 → 2025-03-31 | −¥474m |
| Reconciling Itemsreconciling | capex | 2024-04-01 → 2025-03-31 | ¥1.3bn |
| Reconciling Itemsreconciling | segment assets | at 2025-03-31 | ¥324.3bn |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2025-03-31 | −¥23.8bn |
| Gastrointestinal Solutionsreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥55.1bn |
| Gastrointestinal Solutionsreportable segment | segment assets | at 2025-03-31 | ¥604.3bn |
| Gastrointestinal Solutionsreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥171.4bn |
| Surgical And Interventional Solutionsreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥28.6bn |
| Surgical And Interventional Solutionsreportable segment | segment assets | at 2025-03-31 | ¥500.1bn |
| Surgical And Interventional Solutionsreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥15.3bn |
| —segment total | capex | 2024-04-01 → 2025-03-31 | ¥83.7bn |
| —segment total | segment assets | at 2025-03-31 | ¥1.10T |
| —segment total | segment profit | 2024-04-01 → 2025-03-31 | ¥186.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2026-03-31 | 0 pure |
| Endoscopicreportable segment | employees | at 2026-03-31 | 1259 pure |
| Surgical Interventionreportable segment | employees | at 2026-03-31 | 515 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,964
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of female directors and other officers | FilingDateInstant | 4 | |
| Ratio of female directors and other officers | FilingDateInstant | 0.19 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02272-000IwasakiMasatoMember | 7830 | |
| Number of shares scheduled to be held information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02272-000IwasakiMasatoMember | 7830 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02272-000DavidRobertHaleMember | － | |
| Number of shares scheduled to be held information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02272-000DavidRobertHaleMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02272-000JimmyCBeasleyMember | 12860 | |
| Number of shares scheduled to be held information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02272-000JimmyCBeasleyMember | 7213 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02272-000IchikawaSachikoMember | 14935 | |
| Number of shares scheduled to be held information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02272-000IchikawaSachikoMember | 14935 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02272-000KanKoheiMember | 16667 | |
| Number of shares scheduled to be held information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02272-000KanKoheiMember | 13628 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02272-000GaryJohnPrudenMember | 11512 | |
| Number of shares scheduled to be held information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02272-000GaryJohnPrudenMember | 7213 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02272-000LuannMariePendyMember | 10474 | |
| Number of shares scheduled to be held information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02272-000LuannMariePendyMember | 7213 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02272-000HiroshiIshinoMember | 4729 | |
| Number of shares scheduled to be held information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02272-000HiroshiIshinoMember | 4729 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02272-000TakeuchiYasuoMember | 334026 | |
| Number of shares scheduled to be held information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02272-000TakeuchiYasuoMember | 89030 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02272-000RobertJohnWhiteMember | 193305 | |
| Number of shares scheduled to be held information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02272-000RobertJohnWhiteMember | 193305 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02272-000OkuboToshihikoMember | 31054 | |
| Number of shares scheduled to be held information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02272-000OkuboToshihikoMember | 11390 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant | 637392 | |
| Number of shares scheduled to be held information about directors and corporate auditors | FilingDateInstant | 356486 | |
| Number of shares held ordinary shares information about executive directors | FilingDateInstant_jpcrp030000-asr_E02272-000RobertJohnWhiteMember | 193305 | |
| Number of shares scheduled to be held information about executive directors | FilingDateInstant_jpcrp030000-asr_E02272-000RobertJohnWhiteMember | 193305 | |
| Number of shares held ordinary shares information about executive directors | FilingDateInstant_jpcrp030000-asr_E02272-000SimoneBergerMember | － | |
| Number of shares scheduled to be held information about executive directors | FilingDateInstant_jpcrp030000-asr_E02272-000SimoneBergerMember | － | |
| Number of shares held ordinary shares information about executive directors | FilingDateInstant_jpcrp030000-asr_E02272-000KeithWilliamBoettigerMember | 141843 | |
| Number of shares scheduled to be held information about executive directors | FilingDateInstant_jpcrp030000-asr_E02272-000KeithWilliamBoettigerMember | 141843 | |
| Number of shares held ordinary shares information about executive directors | FilingDateInstant_jpcrp030000-asr_E02272-000JohnManfredDeCsepelMember | 59748 | |
| Number of shares scheduled to be held information about executive directors | FilingDateInstant_jpcrp030000-asr_E02272-000JohnManfredDeCsepelMember | 55588 | |
| Number of shares held ordinary shares information about executive directors | FilingDateInstant_jpcrp030000-asr_E02272-000GabrielaCastilloKaynorMember | 83965 | |
| Number of shares scheduled to be held information about executive directors | FilingDateInstant_jpcrp030000-asr_E02272-000GabrielaCastilloKaynorMember | 64956 | |
| Number of shares held ordinary shares information about executive directors | FilingDateInstant_jpcrp030000-asr_E02272-000KuramotoSeijiMember | 31712 | |
| Number of shares scheduled to be held information about executive directors | FilingDateInstant_jpcrp030000-asr_E02272-000KuramotoSeijiMember | 19558 | |
| Number of shares held ordinary shares information about executive directors | FilingDateInstant_jpcrp030000-asr_E02272-000SyedMukarramNaveedMember | 46682 | |
| Number of shares scheduled to be held information about executive directors | FilingDateInstant_jpcrp030000-asr_E02272-000SyedMukarramNaveedMember | 43694 | |
| Number of shares held ordinary shares information about executive directors | FilingDateInstant_jpcrp030000-asr_E02272-000MichaelAngeloParentiMember | － | |
| Number of shares scheduled to be held information about executive directors | FilingDateInstant_jpcrp030000-asr_E02272-000MichaelAngeloParentiMember | － | |
| Number of shares held ordinary shares information about executive directors | FilingDateInstant_jpcrp030000-asr_E02272-000DavidMichelShanMember | － | |
| Number of shares scheduled to be held information about executive directors | FilingDateInstant_jpcrp030000-asr_E02272-000DavidMichelShanMember | － | |
| Number of shares held ordinary shares information about executive directors | FilingDateInstant_jpcrp030000-asr_E02272-000BorisShkolnikMember | 76110 | |
| Number of shares scheduled to be held information about executive directors | FilingDateInstant_jpcrp030000-asr_E02272-000BorisShkolnikMember | 52344 | |
| Number of shares held ordinary shares information about executive directors | FilingDateInstant_jpcrp030000-asr_E02272-000NeilBoydenTannerMember | 94200 | |
| Number of shares scheduled to be held information about executive directors | FilingDateInstant_jpcrp030000-asr_E02272-000NeilBoydenTannerMember | 83072 | |
| Number of shares held ordinary shares information about executive directors | FilingDateInstant | 727565 | |
| Number of shares scheduled to be held information about executive directors | FilingDateInstant | 654360 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 19 of 19 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |